sec filing
AD
NASDAQ · ADVB
Advanced Biomed Inc. Common Stock
Healthcare · Medical - Diagnostics & Research
$8.85
Up+$0.35 (+4.12%)
Updated Sep 11, 2026, 3:55 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.4M
- P/E ratio
- 17.36
- Dividend yield
- 0.00%
- 52-week range
- $3.61 – $24.23
- Volume
- 121.15K
- Avg. volume
- 52.79K
Price performance
ADVB price history
1M range · 20 trading sessions · Daily adjusted prices
ADVB closed at $8.85 after 20 trading sessions, up 3.15% for the selected period.
- Last close
- $8.85
- Period change
- +3.15%
- Period low
- $8.02
- Period high
- $10.44
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $8.29 | $9.0848 | $8.29 | $8.85 | 121.15K |
| Sep 9, 2026 | $8.84 | $9.04 | $8.38 | $8.50 | 84.74K |
| Sep 8, 2026 | $9.29 | $9.37 | $8.65 | $8.98 | 39.86K |
| Sep 4, 2026 | $9.33 | $9.44 | $9.1021 | $9.335 | 66.46K |
| Sep 3, 2026 | $9.76 | $9.97 | $9.02 | $9.40 | 207.83K |
| Sep 2, 2026 | $10.41 | $10.451 | $9.36 | $9.77 | 86.47K |
| Sep 1, 2026 | $9.36 | $10.80 | $9.20 | $10.44 | 369.64K |
| Aug 31, 2026 | $9.54 | $9.94 | $8.695 | $9.45 | 147.04K |
| Aug 28, 2026 | $9.38 | $9.86 | $9.0101 | $9.70 | 276.76K |
| Aug 27, 2026 | $9.05 | $9.75 | $8.60 | $9.57 | 371.87K |
| Aug 26, 2026 | $9.00 | $10.01 | $8.46 | $9.24 | 570.87K |
| Aug 25, 2026 | $7.92 | $9.39 | $7.6317 | $9.18 | 595.92K |
| Aug 24, 2026 | $7.98 | $8.02 | $7.425 | $8.02 | 190.81K |
| Aug 21, 2026 | $7.84 | $8.14 | $7.20 | $8.14 | 82.89K |
| Aug 20, 2026 | $8.50 | $8.98 | $8.00 | $8.19 | 196.8K |
| Aug 19, 2026 | $8.43 | $9.4103 | $8.35 | $8.35 | 218.82K |
| Aug 18, 2026 | $8.16 | $9.06 | $8.00 | $8.72 | 182.76K |
| Aug 17, 2026 | $8.77 | $9.225 | $7.975 | $8.23 | 176.01K |
| Aug 14, 2026 | $8.80 | $9.4999 | $8.4344 | $8.95 | 486.49K |
| Aug 13, 2026 | $7.40 | $8.88 | $7.40 | $8.58 | 43.64K |
Latest ADVB news
The latest Smart Investors Daily articles mentioning ADVB.
Stock researchResearch & News · Competitors
Loading stock research…